Haemonetics · 1 day ago
Internship - R&D
Boston, MA
Internship
Hybrid
Intern
$20.63/hr - $27.85/hr
Start in 2026 SummerHaemonetics is a company focused on innovation and diversity in the workplace. The R&D Intern will support various Disposables R&D testing projects, contributing to business-critical assignments while gaining valuable experience in a dynamic environment.
BiotechnologyConsultingHealth CareMedicalMedical Device
Responsibilities
Test method development using gage R&R
Test fixture design & fabrication (3D printer & machine shop)
Writing test protocols
Test execution using an Instron (6800 series), leak testers, performing material property analysis (DMA), and running Haemonetics devices such as NexSys PCS
Analyzing results and writing test reports using good documentation practices and statistical analysis
Technical presentations to R&D team members
Qualification
Required
Currently pursuing a Biomedical, Mechanical, or Materials Engineering Degree (rising Junior/ Senior or Graduated Student)
Experience with CAD (SolidWorks)
Machine shop experience
3D printing experience
Prototyping experience
Test fixture design experience
Test execution experience
Benefits
401(k) with up to a 6% employer match and no vesting period
An employee stock purchase plan
Flexible time off for salaried employees
For hourly employees, accrual of three to five weeks’ vacation annually (based on tenure)
Accrual of up to 64 hours (annually) of paid sick time
Paid and/or floating holidays
Parental leave
Short- and long-term disability insurance
Tuition reimbursement
Health and welfare benefits
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
Founded in 1971
1001-5000 employees
H1B Sponsorship
Haemonetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (3)
2022 (2)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Christopher Simon
President and Chief Executive Officer
Christopher Lindop
CFO and VP Business Development
Recent News
2026-01-03
2025-12-02
2025-11-21
Company data provided by crunchbase